Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Japanese Pharma Majors Expanding Into India

This article was originally published in PharmAsia News

Executive Summary

NEW DELHI - Faced with margin pressures elsewhere, pharmaceutical multinationals have been eyeing the burgeoning Indian market ever since the country signed the Trade-Related Aspects of Intellectual Property Rights pact. Initially hesitant, Japanese pharma companies are now following in the footsteps of Western companies, using India as a hub for low-cost contract manufacturing and clinical trials
Advertisement

Related Content

Eisai Plans R&D Revamp To Turn The Development Tide
Eisai Plans R&D Revamp To Turn The Development Tide
Eisai Plans R&D Structure Revamp, Hoping To Turn The Development Tide
Eisai Plans R&D Structure Revamp, Hoping To Turn The Development Tide
Eisai Teams With Accenture In India For Clinical Data Management
Eisai Teams With Accenture In India For Clinical Data Management
Daiichi, Eisai Look Beyond Japan To Expanded Markets In Southeast Asia (Japan)
Advertisement
UsernamePublicRestriction

Register

SC066665

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel